Autoantibodies :: detection, pathogenicity, and health implications /
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
[Hauppauge] New York :
Nova Science Publishers, Incorporated,
[2012]
|
| Schriftenreihe: | Immunology and immune system disorders.
Public health in the 21st century series. |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781620815885 1620815885 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1162041497 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 120312s2012 nyua ob 001 0 eng | ||
| 010 | |a 2020679769 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d VLY |d OCLCO |d YDXCP |d E7B |d N$T |d OCLCF |d EBLCP |d DEBSZ |d AGLDB |d VTS |d AU@ |d STF |d K6U |d OCLCQ |d SNK |d OCLCO |d OCLCQ |d OCLCO |d TMA |d OCLCQ | ||
| 019 | |a 837578466 | ||
| 020 | |a 9781620815885 |q (ebook) | ||
| 020 | |a 1620815885 | ||
| 020 | |z 9781620815601 |q (hardcover) | ||
| 020 | |z 1620815605 |q (hardcover) | ||
| 035 | |a (OCoLC)1162041497 |z (OCoLC)837578466 | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a QR186.82 |
| 072 | 7 | |a MED |x 044000 |2 bisacsh | |
| 082 | 7 | |a 616.07/9 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Autoantibodies : |b detection, pathogenicity, and health implications / |c Graham E. Jenkins and Joanne I. Hall, editors. |
| 264 | 1 | |a [Hauppauge] New York : |b Nova Science Publishers, Incorporated, |c [2012] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Immunology and immune system disorders | |
| 490 | 1 | |a Public health in the 21st century | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 546 | |a English. | ||
| 505 | 0 | |a AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; CONTENTS ; PREFACE ; IMPLICATED AUTOANTIBODIES IN A KIDNEY DISEASE ; ABBREVIATIONS ; ADDITIONAL WELL KNOWN ABBREVIATIONS ; ABSTRACT ; INTRODUCTION ; AUTOIMMUNITY ; DETECTION OF AABS IN THE CIRCULATION AND IN SITU PATHOGENIC AAB RESPONSE AGAINST TARGET ANTIGENIC SITES IN THE KIDNEYS OF SPHN RATS ; PATHOGENICITY OF IGG AABS AGAINST KIDNEY AGS IN SPHN ; NON-PATHOGENIC IGM AABS AGAINST KIDNEY AGS IN SPHN ; HEALTH IMPLICATIONS. | |
| 505 | 8 | |a PREVENTION AND TREATMENT OF A PATHOGENIC IGG AAB INITIATED AND MAINTAINED EXPERIMENTAL AUTOIMMUNE DISEASE BY THE MODIFIED VACCINATION TECHNIQUE (MVT) CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; ANTI-FACTOR H AUTOANTIBODIES IN KIDNEY DISEASE: DETECTION, PATHOGENIC ROLE AND RELEVANCE FOR TREATMENT; ABSTRACT ; INTRODUCTION ; FACTOR H; ANTI-FACTOR H AUTOANTIBODIES; Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome ; Anti-Factor H Autoantibodies in Dense Deposit Disease ; Anti-Factor H Autoantibodies in other Diseases ; DETECTION OF ANTI-FACTOR H AUTOANTIBODIES. | |
| 505 | 8 | |a ARE ANTI-FACTOR H AUTOANTIBODIES PATHOGENIC? RELEVANCE OF THE AUTOANTIBODIES TO TREATMENT ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; AUTOANTIBODIES IN ALZHEIMER'S DISEASE ; ABSTRACT ; INTRODUCTION ; THE BLOOD-BRAIN-BARRIER (BBB): CONNECTION TO THE AD AUTOIMMUNITY HYPOTHESIS; AUTOANTIBODIES AGAINST AB PEPTIDES ; AUTOANTIBODIES AGAINST ATP SYNTHASE ; REDOX REACTIVE AUTOANTIBODIES ; AUTOANTIBODIES AGAINST NICOTINIC ACETYLOCHOLINE RECEPTORS ; AUTOANTIBODIES AGAINST GANGLIOSIDE GM1 ; AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEIN. | |
| 505 | 8 | |a AUTOANTIBODIES AGAINST SERINE/ARGININE PROTEIN KINASE 1 AUTOANTIBODY PROFILES IN HUMAN SERA ; CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; AUTOIMMUNITY IN CARDIOVASCULAR DISEASE; ABSTRACT ; COMMON ABBREVIATIONS USED IN THIS TEXT ; 1.0. DEFINITION OF AUTOIMMUNITY ; 2.0. CLINICAL SIGNIFICANCE OF DILATED CARDIOMYOPATHY AND PREECLAMPSIA ; 2.1. Dilated Cardiomyopathy Characteristics and Prevalence ; 2.2. Preeclampsia Characteristics and Prevalence ; 3.0. DILATED CARDIOMYOPATHY AUTOANTIBODY IMPORTANCE ; 3.1. Ý1-Adrenergic Receptor Agonistic Autoantibody (Ý1R-AA) | |
| 505 | 8 | |a 3.2. Muscarinic M2 Receptor Agonistic Autoantibody (M2R-AA) 3.3. Clinical Significance ; 4.0. AUTOANTIBODY AND SIGNIFICANCE IN PREECLAMPSIA ; 4.1. In Vitro Studies of PE ; 4.2. Effects of PE in Various Laboratory and Clinical Settings ; A. Mouse Studies with Adoptive Transfer ; B. Rat Studies with Adoptive Transfer ; C. Human Evidence Supporting Autoantibody Role in PE ; 5.0. AUTOANTIBODY RECEPTOR BINDING AND PRODUCTION ; 5.1. Mechanisms Underlying Ý1R-AA Production ; 5.2. Mechanisms Underlying AT1-AA Production and Function; 6.0. THERAPEUTIC CONSIDERATIONS. | |
| 650 | 0 | |a Autoantibodies. |0 http://id.loc.gov/authorities/subjects/sh85010046 | |
| 650 | 0 | |a Autoantibodies |x Analysis. |0 http://id.loc.gov/authorities/subjects/sh85010047 | |
| 650 | 0 | |a Autoimmunity. |0 http://id.loc.gov/authorities/subjects/sh87006465 | |
| 650 | 2 | |a Autoantibodies |0 https://id.nlm.nih.gov/mesh/D001323 | |
| 650 | 2 | |a Autoimmunity |0 https://id.nlm.nih.gov/mesh/D015551 | |
| 650 | 6 | |a Autoanticorps. | |
| 650 | 6 | |a Autoanticorps |x Analyse. | |
| 650 | 6 | |a Auto-immunité. | |
| 650 | 7 | |a MEDICAL |x Immunology. |2 bisacsh | |
| 650 | 7 | |a Autoantibodies |2 fast | |
| 650 | 7 | |a Autoantibodies |x Analysis |2 fast | |
| 650 | 7 | |a Autoimmunity |2 fast | |
| 700 | 1 | |a Jenkins, Graham E., |e editor. | |
| 700 | 1 | |a Hall, Joanne I., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Autoantibodies. |d [Hauppauge] New York : Nova Science Publishers, Inc., [2012] |z 9781620815601 |w (DLC) 2012935164 |
| 830 | 0 | |a Immunology and immune system disorders. |0 http://id.loc.gov/authorities/names/n2010183470 | |
| 830 | 0 | |a Public health in the 21st century series. |0 http://id.loc.gov/authorities/names/n2010180172 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541271 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3020980 | ||
| 938 | |a ebrary |b EBRY |n ebr10681180 | ||
| 938 | |a EBSCOhost |b EBSC |n 541271 | ||
| 938 | |a YBP Library Services |b YANK |n 9371477 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1162041497 |
|---|---|
| _version_ | 1816882521696108544 |
| adam_text | |
| any_adam_object | |
| author2 | Jenkins, Graham E. Hall, Joanne I. |
| author2_role | edt edt |
| author2_variant | g e j ge gej j i h ji jih |
| author_facet | Jenkins, Graham E. Hall, Joanne I. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | Q - Science |
| callnumber-label | QR186 |
| callnumber-raw | QR186.82 |
| callnumber-search | QR186.82 |
| callnumber-sort | QR 3186.82 |
| callnumber-subject | QR - Microbiology |
| collection | ZDB-4-EBA |
| contents | AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; CONTENTS ; PREFACE ; IMPLICATED AUTOANTIBODIES IN A KIDNEY DISEASE ; ABBREVIATIONS ; ADDITIONAL WELL KNOWN ABBREVIATIONS ; ABSTRACT ; INTRODUCTION ; AUTOIMMUNITY ; DETECTION OF AABS IN THE CIRCULATION AND IN SITU PATHOGENIC AAB RESPONSE AGAINST TARGET ANTIGENIC SITES IN THE KIDNEYS OF SPHN RATS ; PATHOGENICITY OF IGG AABS AGAINST KIDNEY AGS IN SPHN ; NON-PATHOGENIC IGM AABS AGAINST KIDNEY AGS IN SPHN ; HEALTH IMPLICATIONS. PREVENTION AND TREATMENT OF A PATHOGENIC IGG AAB INITIATED AND MAINTAINED EXPERIMENTAL AUTOIMMUNE DISEASE BY THE MODIFIED VACCINATION TECHNIQUE (MVT) CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; ANTI-FACTOR H AUTOANTIBODIES IN KIDNEY DISEASE: DETECTION, PATHOGENIC ROLE AND RELEVANCE FOR TREATMENT; ABSTRACT ; INTRODUCTION ; FACTOR H; ANTI-FACTOR H AUTOANTIBODIES; Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome ; Anti-Factor H Autoantibodies in Dense Deposit Disease ; Anti-Factor H Autoantibodies in other Diseases ; DETECTION OF ANTI-FACTOR H AUTOANTIBODIES. ARE ANTI-FACTOR H AUTOANTIBODIES PATHOGENIC? RELEVANCE OF THE AUTOANTIBODIES TO TREATMENT ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; AUTOANTIBODIES IN ALZHEIMER'S DISEASE ; ABSTRACT ; INTRODUCTION ; THE BLOOD-BRAIN-BARRIER (BBB): CONNECTION TO THE AD AUTOIMMUNITY HYPOTHESIS; AUTOANTIBODIES AGAINST AB PEPTIDES ; AUTOANTIBODIES AGAINST ATP SYNTHASE ; REDOX REACTIVE AUTOANTIBODIES ; AUTOANTIBODIES AGAINST NICOTINIC ACETYLOCHOLINE RECEPTORS ; AUTOANTIBODIES AGAINST GANGLIOSIDE GM1 ; AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEIN. AUTOANTIBODIES AGAINST SERINE/ARGININE PROTEIN KINASE 1 AUTOANTIBODY PROFILES IN HUMAN SERA ; CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; AUTOIMMUNITY IN CARDIOVASCULAR DISEASE; ABSTRACT ; COMMON ABBREVIATIONS USED IN THIS TEXT ; 1.0. DEFINITION OF AUTOIMMUNITY ; 2.0. CLINICAL SIGNIFICANCE OF DILATED CARDIOMYOPATHY AND PREECLAMPSIA ; 2.1. Dilated Cardiomyopathy Characteristics and Prevalence ; 2.2. Preeclampsia Characteristics and Prevalence ; 3.0. DILATED CARDIOMYOPATHY AUTOANTIBODY IMPORTANCE ; 3.1. Ý1-Adrenergic Receptor Agonistic Autoantibody (Ý1R-AA) 3.2. Muscarinic M2 Receptor Agonistic Autoantibody (M2R-AA) 3.3. Clinical Significance ; 4.0. AUTOANTIBODY AND SIGNIFICANCE IN PREECLAMPSIA ; 4.1. In Vitro Studies of PE ; 4.2. Effects of PE in Various Laboratory and Clinical Settings ; A. Mouse Studies with Adoptive Transfer ; B. Rat Studies with Adoptive Transfer ; C. Human Evidence Supporting Autoantibody Role in PE ; 5.0. AUTOANTIBODY RECEPTOR BINDING AND PRODUCTION ; 5.1. Mechanisms Underlying Ý1R-AA Production ; 5.2. Mechanisms Underlying AT1-AA Production and Function; 6.0. THERAPEUTIC CONSIDERATIONS. |
| ctrlnum | (OCoLC)1162041497 |
| dewey-full | 616.07/9 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.07/9 |
| dewey-search | 616.07/9 |
| dewey-sort | 3616.07 19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05716cam a2200721 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1162041497</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">120312s2012 nyua ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2020679769</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">DLC</subfield><subfield code="d">VLY</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDXCP</subfield><subfield code="d">E7B</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">EBLCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">AGLDB</subfield><subfield code="d">VTS</subfield><subfield code="d">AU@</subfield><subfield code="d">STF</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SNK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">TMA</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">837578466</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781620815885</subfield><subfield code="q">(ebook)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1620815885</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781620815601</subfield><subfield code="q">(hardcover)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1620815605</subfield><subfield code="q">(hardcover)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1162041497</subfield><subfield code="z">(OCoLC)837578466</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1="0" ind2="0"><subfield code="a">QR186.82</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">044000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.07/9</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Autoantibodies :</subfield><subfield code="b">detection, pathogenicity, and health implications /</subfield><subfield code="c">Graham E. Jenkins and Joanne I. Hall, editors.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Hauppauge] New York :</subfield><subfield code="b">Nova Science Publishers, Incorporated,</subfield><subfield code="c">[2012]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Immunology and immune system disorders</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Public health in the 21st century</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record and CIP data provided by publisher.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; CONTENTS ; PREFACE ; IMPLICATED AUTOANTIBODIES IN A KIDNEY DISEASE ; ABBREVIATIONS ; ADDITIONAL WELL KNOWN ABBREVIATIONS ; ABSTRACT ; INTRODUCTION ; AUTOIMMUNITY ; DETECTION OF AABS IN THE CIRCULATION AND IN SITU PATHOGENIC AAB RESPONSE AGAINST TARGET ANTIGENIC SITES IN THE KIDNEYS OF SPHN RATS ; PATHOGENICITY OF IGG AABS AGAINST KIDNEY AGS IN SPHN ; NON-PATHOGENIC IGM AABS AGAINST KIDNEY AGS IN SPHN ; HEALTH IMPLICATIONS.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">PREVENTION AND TREATMENT OF A PATHOGENIC IGG AAB INITIATED AND MAINTAINED EXPERIMENTAL AUTOIMMUNE DISEASE BY THE MODIFIED VACCINATION TECHNIQUE (MVT) CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; ANTI-FACTOR H AUTOANTIBODIES IN KIDNEY DISEASE: DETECTION, PATHOGENIC ROLE AND RELEVANCE FOR TREATMENT; ABSTRACT ; INTRODUCTION ; FACTOR H; ANTI-FACTOR H AUTOANTIBODIES; Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome ; Anti-Factor H Autoantibodies in Dense Deposit Disease ; Anti-Factor H Autoantibodies in other Diseases ; DETECTION OF ANTI-FACTOR H AUTOANTIBODIES.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">ARE ANTI-FACTOR H AUTOANTIBODIES PATHOGENIC? RELEVANCE OF THE AUTOANTIBODIES TO TREATMENT ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; AUTOANTIBODIES IN ALZHEIMER'S DISEASE ; ABSTRACT ; INTRODUCTION ; THE BLOOD-BRAIN-BARRIER (BBB): CONNECTION TO THE AD AUTOIMMUNITY HYPOTHESIS; AUTOANTIBODIES AGAINST AB PEPTIDES ; AUTOANTIBODIES AGAINST ATP SYNTHASE ; REDOX REACTIVE AUTOANTIBODIES ; AUTOANTIBODIES AGAINST NICOTINIC ACETYLOCHOLINE RECEPTORS ; AUTOANTIBODIES AGAINST GANGLIOSIDE GM1 ; AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEIN.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">AUTOANTIBODIES AGAINST SERINE/ARGININE PROTEIN KINASE 1 AUTOANTIBODY PROFILES IN HUMAN SERA ; CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; AUTOIMMUNITY IN CARDIOVASCULAR DISEASE; ABSTRACT ; COMMON ABBREVIATIONS USED IN THIS TEXT ; 1.0. DEFINITION OF AUTOIMMUNITY ; 2.0. CLINICAL SIGNIFICANCE OF DILATED CARDIOMYOPATHY AND PREECLAMPSIA ; 2.1. Dilated Cardiomyopathy Characteristics and Prevalence ; 2.2. Preeclampsia Characteristics and Prevalence ; 3.0. DILATED CARDIOMYOPATHY AUTOANTIBODY IMPORTANCE ; 3.1. Ý1-Adrenergic Receptor Agonistic Autoantibody (Ý1R-AA)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.2. Muscarinic M2 Receptor Agonistic Autoantibody (M2R-AA) 3.3. Clinical Significance ; 4.0. AUTOANTIBODY AND SIGNIFICANCE IN PREECLAMPSIA ; 4.1. In Vitro Studies of PE ; 4.2. Effects of PE in Various Laboratory and Clinical Settings ; A. Mouse Studies with Adoptive Transfer ; B. Rat Studies with Adoptive Transfer ; C. Human Evidence Supporting Autoantibody Role in PE ; 5.0. AUTOANTIBODY RECEPTOR BINDING AND PRODUCTION ; 5.1. Mechanisms Underlying Ý1R-AA Production ; 5.2. Mechanisms Underlying AT1-AA Production and Function; 6.0. THERAPEUTIC CONSIDERATIONS.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Autoantibodies.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85010046</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Autoantibodies</subfield><subfield code="x">Analysis.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85010047</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Autoimmunity.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh87006465</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Autoantibodies</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D001323</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Autoimmunity</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D015551</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Autoanticorps.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Autoanticorps</subfield><subfield code="x">Analyse.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Auto-immunité.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Immunology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Autoantibodies</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Autoantibodies</subfield><subfield code="x">Analysis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Autoimmunity</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jenkins, Graham E.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hall, Joanne I.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Autoantibodies.</subfield><subfield code="d">[Hauppauge] New York : Nova Science Publishers, Inc., [2012]</subfield><subfield code="z">9781620815601</subfield><subfield code="w">(DLC) 2012935164</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Immunology and immune system disorders.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010183470</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Public health in the 21st century series.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010180172</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541271</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3020980</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10681180</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">541271</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">9371477</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1162041497 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:29:56Z |
| institution | BVB |
| isbn | 9781620815885 1620815885 |
| language | English |
| lccn | 2020679769 |
| oclc_num | 1162041497 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBA |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Nova Science Publishers, Incorporated, |
| record_format | marc |
| series | Immunology and immune system disorders. Public health in the 21st century series. |
| series2 | Immunology and immune system disorders Public health in the 21st century |
| spelling | Autoantibodies : detection, pathogenicity, and health implications / Graham E. Jenkins and Joanne I. Hall, editors. [Hauppauge] New York : Nova Science Publishers, Incorporated, [2012] 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Immunology and immune system disorders Public health in the 21st century Includes bibliographical references and index. Print version record and CIP data provided by publisher. English. AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; CONTENTS ; PREFACE ; IMPLICATED AUTOANTIBODIES IN A KIDNEY DISEASE ; ABBREVIATIONS ; ADDITIONAL WELL KNOWN ABBREVIATIONS ; ABSTRACT ; INTRODUCTION ; AUTOIMMUNITY ; DETECTION OF AABS IN THE CIRCULATION AND IN SITU PATHOGENIC AAB RESPONSE AGAINST TARGET ANTIGENIC SITES IN THE KIDNEYS OF SPHN RATS ; PATHOGENICITY OF IGG AABS AGAINST KIDNEY AGS IN SPHN ; NON-PATHOGENIC IGM AABS AGAINST KIDNEY AGS IN SPHN ; HEALTH IMPLICATIONS. PREVENTION AND TREATMENT OF A PATHOGENIC IGG AAB INITIATED AND MAINTAINED EXPERIMENTAL AUTOIMMUNE DISEASE BY THE MODIFIED VACCINATION TECHNIQUE (MVT) CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; ANTI-FACTOR H AUTOANTIBODIES IN KIDNEY DISEASE: DETECTION, PATHOGENIC ROLE AND RELEVANCE FOR TREATMENT; ABSTRACT ; INTRODUCTION ; FACTOR H; ANTI-FACTOR H AUTOANTIBODIES; Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome ; Anti-Factor H Autoantibodies in Dense Deposit Disease ; Anti-Factor H Autoantibodies in other Diseases ; DETECTION OF ANTI-FACTOR H AUTOANTIBODIES. ARE ANTI-FACTOR H AUTOANTIBODIES PATHOGENIC? RELEVANCE OF THE AUTOANTIBODIES TO TREATMENT ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; AUTOANTIBODIES IN ALZHEIMER'S DISEASE ; ABSTRACT ; INTRODUCTION ; THE BLOOD-BRAIN-BARRIER (BBB): CONNECTION TO THE AD AUTOIMMUNITY HYPOTHESIS; AUTOANTIBODIES AGAINST AB PEPTIDES ; AUTOANTIBODIES AGAINST ATP SYNTHASE ; REDOX REACTIVE AUTOANTIBODIES ; AUTOANTIBODIES AGAINST NICOTINIC ACETYLOCHOLINE RECEPTORS ; AUTOANTIBODIES AGAINST GANGLIOSIDE GM1 ; AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEIN. AUTOANTIBODIES AGAINST SERINE/ARGININE PROTEIN KINASE 1 AUTOANTIBODY PROFILES IN HUMAN SERA ; CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; AUTOIMMUNITY IN CARDIOVASCULAR DISEASE; ABSTRACT ; COMMON ABBREVIATIONS USED IN THIS TEXT ; 1.0. DEFINITION OF AUTOIMMUNITY ; 2.0. CLINICAL SIGNIFICANCE OF DILATED CARDIOMYOPATHY AND PREECLAMPSIA ; 2.1. Dilated Cardiomyopathy Characteristics and Prevalence ; 2.2. Preeclampsia Characteristics and Prevalence ; 3.0. DILATED CARDIOMYOPATHY AUTOANTIBODY IMPORTANCE ; 3.1. Ý1-Adrenergic Receptor Agonistic Autoantibody (Ý1R-AA) 3.2. Muscarinic M2 Receptor Agonistic Autoantibody (M2R-AA) 3.3. Clinical Significance ; 4.0. AUTOANTIBODY AND SIGNIFICANCE IN PREECLAMPSIA ; 4.1. In Vitro Studies of PE ; 4.2. Effects of PE in Various Laboratory and Clinical Settings ; A. Mouse Studies with Adoptive Transfer ; B. Rat Studies with Adoptive Transfer ; C. Human Evidence Supporting Autoantibody Role in PE ; 5.0. AUTOANTIBODY RECEPTOR BINDING AND PRODUCTION ; 5.1. Mechanisms Underlying Ý1R-AA Production ; 5.2. Mechanisms Underlying AT1-AA Production and Function; 6.0. THERAPEUTIC CONSIDERATIONS. Autoantibodies. http://id.loc.gov/authorities/subjects/sh85010046 Autoantibodies Analysis. http://id.loc.gov/authorities/subjects/sh85010047 Autoimmunity. http://id.loc.gov/authorities/subjects/sh87006465 Autoantibodies https://id.nlm.nih.gov/mesh/D001323 Autoimmunity https://id.nlm.nih.gov/mesh/D015551 Autoanticorps. Autoanticorps Analyse. Auto-immunité. MEDICAL Immunology. bisacsh Autoantibodies fast Autoantibodies Analysis fast Autoimmunity fast Jenkins, Graham E., editor. Hall, Joanne I., editor. Print version: Autoantibodies. [Hauppauge] New York : Nova Science Publishers, Inc., [2012] 9781620815601 (DLC) 2012935164 Immunology and immune system disorders. http://id.loc.gov/authorities/names/n2010183470 Public health in the 21st century series. http://id.loc.gov/authorities/names/n2010180172 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541271 Volltext |
| spellingShingle | Autoantibodies : detection, pathogenicity, and health implications / Immunology and immune system disorders. Public health in the 21st century series. AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; CONTENTS ; PREFACE ; IMPLICATED AUTOANTIBODIES IN A KIDNEY DISEASE ; ABBREVIATIONS ; ADDITIONAL WELL KNOWN ABBREVIATIONS ; ABSTRACT ; INTRODUCTION ; AUTOIMMUNITY ; DETECTION OF AABS IN THE CIRCULATION AND IN SITU PATHOGENIC AAB RESPONSE AGAINST TARGET ANTIGENIC SITES IN THE KIDNEYS OF SPHN RATS ; PATHOGENICITY OF IGG AABS AGAINST KIDNEY AGS IN SPHN ; NON-PATHOGENIC IGM AABS AGAINST KIDNEY AGS IN SPHN ; HEALTH IMPLICATIONS. PREVENTION AND TREATMENT OF A PATHOGENIC IGG AAB INITIATED AND MAINTAINED EXPERIMENTAL AUTOIMMUNE DISEASE BY THE MODIFIED VACCINATION TECHNIQUE (MVT) CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; ANTI-FACTOR H AUTOANTIBODIES IN KIDNEY DISEASE: DETECTION, PATHOGENIC ROLE AND RELEVANCE FOR TREATMENT; ABSTRACT ; INTRODUCTION ; FACTOR H; ANTI-FACTOR H AUTOANTIBODIES; Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome ; Anti-Factor H Autoantibodies in Dense Deposit Disease ; Anti-Factor H Autoantibodies in other Diseases ; DETECTION OF ANTI-FACTOR H AUTOANTIBODIES. ARE ANTI-FACTOR H AUTOANTIBODIES PATHOGENIC? RELEVANCE OF THE AUTOANTIBODIES TO TREATMENT ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; AUTOANTIBODIES IN ALZHEIMER'S DISEASE ; ABSTRACT ; INTRODUCTION ; THE BLOOD-BRAIN-BARRIER (BBB): CONNECTION TO THE AD AUTOIMMUNITY HYPOTHESIS; AUTOANTIBODIES AGAINST AB PEPTIDES ; AUTOANTIBODIES AGAINST ATP SYNTHASE ; REDOX REACTIVE AUTOANTIBODIES ; AUTOANTIBODIES AGAINST NICOTINIC ACETYLOCHOLINE RECEPTORS ; AUTOANTIBODIES AGAINST GANGLIOSIDE GM1 ; AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEIN. AUTOANTIBODIES AGAINST SERINE/ARGININE PROTEIN KINASE 1 AUTOANTIBODY PROFILES IN HUMAN SERA ; CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; AUTOIMMUNITY IN CARDIOVASCULAR DISEASE; ABSTRACT ; COMMON ABBREVIATIONS USED IN THIS TEXT ; 1.0. DEFINITION OF AUTOIMMUNITY ; 2.0. CLINICAL SIGNIFICANCE OF DILATED CARDIOMYOPATHY AND PREECLAMPSIA ; 2.1. Dilated Cardiomyopathy Characteristics and Prevalence ; 2.2. Preeclampsia Characteristics and Prevalence ; 3.0. DILATED CARDIOMYOPATHY AUTOANTIBODY IMPORTANCE ; 3.1. Ý1-Adrenergic Receptor Agonistic Autoantibody (Ý1R-AA) 3.2. Muscarinic M2 Receptor Agonistic Autoantibody (M2R-AA) 3.3. Clinical Significance ; 4.0. AUTOANTIBODY AND SIGNIFICANCE IN PREECLAMPSIA ; 4.1. In Vitro Studies of PE ; 4.2. Effects of PE in Various Laboratory and Clinical Settings ; A. Mouse Studies with Adoptive Transfer ; B. Rat Studies with Adoptive Transfer ; C. Human Evidence Supporting Autoantibody Role in PE ; 5.0. AUTOANTIBODY RECEPTOR BINDING AND PRODUCTION ; 5.1. Mechanisms Underlying Ý1R-AA Production ; 5.2. Mechanisms Underlying AT1-AA Production and Function; 6.0. THERAPEUTIC CONSIDERATIONS. Autoantibodies. http://id.loc.gov/authorities/subjects/sh85010046 Autoantibodies Analysis. http://id.loc.gov/authorities/subjects/sh85010047 Autoimmunity. http://id.loc.gov/authorities/subjects/sh87006465 Autoantibodies https://id.nlm.nih.gov/mesh/D001323 Autoimmunity https://id.nlm.nih.gov/mesh/D015551 Autoanticorps. Autoanticorps Analyse. Auto-immunité. MEDICAL Immunology. bisacsh Autoantibodies fast Autoantibodies Analysis fast Autoimmunity fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85010046 http://id.loc.gov/authorities/subjects/sh85010047 http://id.loc.gov/authorities/subjects/sh87006465 https://id.nlm.nih.gov/mesh/D001323 https://id.nlm.nih.gov/mesh/D015551 |
| title | Autoantibodies : detection, pathogenicity, and health implications / |
| title_auth | Autoantibodies : detection, pathogenicity, and health implications / |
| title_exact_search | Autoantibodies : detection, pathogenicity, and health implications / |
| title_full | Autoantibodies : detection, pathogenicity, and health implications / Graham E. Jenkins and Joanne I. Hall, editors. |
| title_fullStr | Autoantibodies : detection, pathogenicity, and health implications / Graham E. Jenkins and Joanne I. Hall, editors. |
| title_full_unstemmed | Autoantibodies : detection, pathogenicity, and health implications / Graham E. Jenkins and Joanne I. Hall, editors. |
| title_short | Autoantibodies : |
| title_sort | autoantibodies detection pathogenicity and health implications |
| title_sub | detection, pathogenicity, and health implications / |
| topic | Autoantibodies. http://id.loc.gov/authorities/subjects/sh85010046 Autoantibodies Analysis. http://id.loc.gov/authorities/subjects/sh85010047 Autoimmunity. http://id.loc.gov/authorities/subjects/sh87006465 Autoantibodies https://id.nlm.nih.gov/mesh/D001323 Autoimmunity https://id.nlm.nih.gov/mesh/D015551 Autoanticorps. Autoanticorps Analyse. Auto-immunité. MEDICAL Immunology. bisacsh Autoantibodies fast Autoantibodies Analysis fast Autoimmunity fast |
| topic_facet | Autoantibodies. Autoantibodies Analysis. Autoimmunity. Autoantibodies Autoimmunity Autoanticorps. Autoanticorps Analyse. Auto-immunité. MEDICAL Immunology. Autoantibodies Analysis |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541271 |
| work_keys_str_mv | AT jenkinsgrahame autoantibodiesdetectionpathogenicityandhealthimplications AT halljoannei autoantibodiesdetectionpathogenicityandhealthimplications |